Follow The Filings

VMD Viemed Healthcare Inc.

Health Care, filed as VIEMED HEALTHCARE INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • Max 0.0%
  • $6.1M
  • 1 add

In 2026 Q2 First Eagle Investment Management added to Viemed Healthcare.

Who owns this now

Largest portfolio weights among holders, up to 0.0% (First Eagle Investment Management). Not free-float ownership.

  1. First Eagle Investment Manage... Add 0.01%

Who owns VMD

Sorted by value, long equity only, as of 2026 Q2.

History
First Eagle Investment Management 0.01% Add +1.0% 535,157 $6.1M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by VMD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VMD insider trades
  • None no insider bought on the open market
  • $1.6M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. William Frazier Chief Medical Officer
    Sale
    $117K 10,000 shares at $11.72 12% of stake
    Traded Jun 25 Filed Jun 26
    ↗
  2. Timothy Smokoff Director
    Sale
    $230K 20,000 shares at $11.50 21% of stake
    Traded Jun 24 Filed Jun 26
    ↗
  3. Michael Moore President
    Sale
    $1.2M 136,802 shares at $9.05 7.9% of stake
    Traded Mar 18–20 Filed Mar 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 48 option exercises, 23 sales back to the company, and 20 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc
10-K Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $183.01M $224.26M $270.28M
Gross profit $112.78M $133.2M $155.46M
Gross margin * 61.6% 59.4% 57.5%
Net income $10.24M $11.26M $14.93M
Net margin * 5.6% 5.0% 5.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $38.37M $52.88M $48.49M
Total non-current assets $116.53M $124.19M $150.66M
Total assets $154.9M $177.07M $199.15M
Total current liabilities $32.12M $37.33M $41.06M
Total non-current liabilities $8.88M $6.44M $14.58M
Total equity $113.9M $131.39M $141.54M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $45.21M $39.09M $51.92M
Cash from investing -$52.11M -$30.7M -$50.17M
Cash from financing $2.83M -$3.69M -$5.79M
Net change in cash -$4.08M $4.7M -$4.04M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.